OCSOculis Holding AG Ordinary shares

13.09USDMkt Cap: 726.58M $P/E:

Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic, neuro-ophthalmic, and neurological diseases in Switzerland and internationally. The company's lead product cand…

Key Statistics

Company
Market Cap726.58M $
Enterprise Value585.38M $
Revenue (TTM)1.17M $
Gross Profit-55.56M $
Net Income (TTM)-98.96M $
Revenue/Share0.0210 USD
Last Price13.09 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees60
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-6.48
PEG
EV/EBITDA-6.81
EV/Revenue499.04
P/S622.03
P/B3.26
EPS (TTM)-1.70
EPS (Forward)-2.03
52W Range
13.0031% of range13.27
52W High13.27 USD
52W Low13.00 USD
Profitability
Gross Margin0.00%
Oper. Margin-7602.58%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-50.47%
ROA-41.94%
Growth
Revenue Growth18.80%
Earnings Growth
Cash Flow & Leverage
Operating CF-66.30M $
CapEx (TTM)1.39M $
FCF Margin-3527.09%
FCF Yield-5.69%
Net Debt-225.78M $
Net Debt/EBITDA2.63
Balance Sheet
Debt/Equity0.01
Current Ratio8.35
Quick Ratio8.24
Book Value/Sh4.031 USD
Cash/Share3.699 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)36.51 USD
Upside (mean)+179.0%
Target Range20.31 USD45.43 USD
$20.31+179.0% to mean$45.43
# Analysts10
Ownership
Shares Out.55.53M
Float52.41M
Insiders3.53%
Institutions47.56%
Short Interest
Short Ratio4.1d
Short % Float3.08%
Short % Out.2.63%
Shares Short1.46M
Short (prev mo.)1.18M
Technical
SMA 5012.27 (+6.6%)
SMA 20021.45 (-39.0%)
Beta0.23
S&P 52W Chg21.00%
Avg Vol (30d)76.44K
Avg Vol (10d)232.92K
Technical Indicators
RSI (14)54.5
MACD0.1116
MACD Signal-0.0843
MACD Hist.+0.1958
BB Upper14.04 USD
BB Middle12.34 USD
BB Lower10.63 USD
BB Width27.64%
ATR (14)0.5993 USD
Vol Ratio (20d)0.27x